Potential for vitamin D receptor agonists in the treatment of cardiovascular disease
Published 2009 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Potential for vitamin D receptor agonists in the treatment of cardiovascular disease
Authors
Keywords
-
Journal
BRITISH JOURNAL OF PHARMACOLOGY
Volume 158, Issue 2, Pages 395-412
Publisher
Wiley
Online
2009-04-10
DOI
10.1111/j.1476-5381.2009.00171.x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Systematic Review: Comparative Effectiveness of Treatments to Prevent Fractures in Men and Women with Low Bone Density or Osteoporosis
- (2013) Catherine MacLean et al. ANNALS OF INTERNAL MEDICINE
- 1,25-Dihydroxyvitamin-D3 Treatment Reduces Cardiac Hypertrophy and Left Ventricular Diameter in Spontaneously Hypertensive Heart Failure-prone (cp/+) Rats Independent of Changes in Serum Leptin
- (2009) Peter Mancuso et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Variability and Risk Factors for Kidney Disease Progression and Death Following Attainment of Stage 4 CKD in a Referred Cohort
- (2008) Adeera Levin et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Oral Calcitriol for the Treatment of Persistent Proteinuria in Immunoglobulin A Nephropathy: An Uncontrolled Trial
- (2008) Cheuk-Chun Szeto et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Vitamin D derivatives acutely reduce endothelium-dependent contractions in the aorta of the spontaneously hypertensive rat
- (2008) Michael S. K. Wong et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Vitamin D supplementation in early childhood and risk of type 1 diabetes: a systematic review and meta-analysis
- (2008) C S Zipitis et al. ARCHIVES OF DISEASE IN CHILDHOOD
- 25-Hydroxyvitamin D Levels and the Risk of Mortality in the General Population
- (2008) M. L. Melamed et al. ARCHIVES OF INTERNAL MEDICINE
- Association of Activated Vitamin D Treatment and Mortality in Chronic Kidney Disease
- (2008) Csaba P. Kovesdy ARCHIVES OF INTERNAL MEDICINE
- 25-Hydroxyvitamin D and Risk of Myocardial Infarction in MenA Prospective Study
- (2008) Edward Giovannucci ARCHIVES OF INTERNAL MEDICINE
- Independent Association of Low Serum 25-Hydroxyvitamin D and 1,25-Dihydroxyvitamin D Levels With All-Cause and Cardiovascular Mortality
- (2008) Harald Dobnig ARCHIVES OF INTERNAL MEDICINE
- Differential Effects of D-Hormone Analogs and Native Vitamin D on the Risk of Falls: A Comparative Meta-Analysis
- (2008) Florent Richy et al. CALCIFIED TISSUE INTERNATIONAL
- Vitamin D Deficiency and Risk of Cardiovascular Disease
- (2008) Thomas J. Wang et al. CIRCULATION
- Ratio of Paricalcitol Dosage to Serum Parathyroid Hormone Level and Survival in Maintenance Hemodialysis Patients
- (2008) C. S. Shinaberger et al. Clinical Journal of the American Society of Nephrology
- Vitamin D and Kidney Disease
- (2008) W. Al-Badr et al. Clinical Journal of the American Society of Nephrology
- Contribution of Bone and Mineral Abnormalities to Cardiovascular Disease in Patients with Chronic Kidney Disease
- (2008) P. Raggi et al. Clinical Journal of the American Society of Nephrology
- Vitamin D improves endothelial function in patients with Type 2 diabetes mellitus and low vitamin D levels
- (2008) J. A. Sugden et al. DIABETIC MEDICINE
- Calcitriol blunts pro-atherosclerotic parameters through NFB and p38in vitro
- (2008) Y. Talmor et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Dietary Intake of Dairy Products, Calcium, and Vitamin D and the Risk of Hypertension in Middle-Aged and Older Women
- (2008) Lu Wang et al. HYPERTENSION
- Paricalcitol Reduces Albuminuria and Inflammation in Chronic Kidney Disease
- (2008) Pooneh Alborzi et al. HYPERTENSION
- Impact of Activated Vitamin D and Race on Survival among Hemodialysis Patients
- (2008) M. Wolf et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Vitamin D Receptor Activators Can Protect against Vascular Calcification
- (2008) S. Mathew et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Paricalcitol Inhibits Renal Inflammation by Promoting Vitamin D Receptor-Mediated Sequestration of NF- B Signaling
- (2008) X. Tan et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Association of Oral Calcitriol with Improved Survival in Nondialyzed CKD
- (2008) A. B. Shoben et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Oral active vitamin D is associated with improved survival in hemodialysis patients
- (2008) Manuel Naves-Díaz et al. KIDNEY INTERNATIONAL
- Suppression of renin–angiotensin gene expression in the kidney by paricalcitol
- (2008) Michael Freundlich et al. KIDNEY INTERNATIONAL
- Calcium-independent and 1,25(OH)2D3-dependent regulation of the renin-angiotensin system in 1α-hydroxylase knockout mice
- (2008) Chunlei Zhou et al. KIDNEY INTERNATIONAL
- Mortality reduction by vitamin D receptor activation in end-stage renal disease: a commentary on the robustness of current data
- (2008) M. G. Vervloet et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Differential effects of vitamin D receptor activators on aortic calcification and pulse wave velocity in uraemic rats
- (2008) W. Noonan et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Combination therapy with AT1 blocker and vitamin D analog markedly ameliorates diabetic nephropathy: Blockade of compensatory renin increase
- (2008) Z. Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Role of vitamin D in the pathogenesis of type 2 diabetes mellitus
- (2007) X. Palomer et al. DIABETES OBESITY & METABOLISM
- The effect of calcitriol, paricalcitol, and a calcimimetic on extraosseous calcifications in uremic rats
- (2007) I. Lopez et al. KIDNEY INTERNATIONAL
- Renoprotective role of the vitamin D receptor in diabetic nephropathy
- (2007) Z. Zhang et al. KIDNEY INTERNATIONAL
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started